Filing Details
- Accession Number:
- 0001209191-11-039009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-08 21:03:06
- Reporting Period:
- 2011-07-06
- Filing Date:
- 2011-07-08
- Accepted Time:
- 2011-07-08 21:03:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103390 | Ardea Biosciences Inc. | RDEA | Pharmaceutical Preparations (2834) | 943200380 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131146 | Stephen Davis | 4939 Directors Place San Diego CA 92121 | Evp & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-07-06 | 191 | $25.33 | 19,351 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2011-07-06 | 700 | $25.65 | 18,651 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents vested shares of restricted stock that were withheld by the Issuer to satisfy the tax liability associated with the 521 shares that vested on July 6, 2011.
- The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 23, 2010.
- The range of sales prices received was $25.39 to $25.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
